Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2019-07-13
2020-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Group 1 (G1), received the FGG two months before implant placement.
* Group 2 (G2), received the FGG at the time of second-stage surgery (i.e. at the time of healing abutment placement).
All periodontal and radiographic assessments were done by the same operator who was neither involved in the evaluation nor the distribution process. The operator did all the evaluation steps and was completely blinded to the treatment protocol.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Soft Tissue Augmentation Technique Using Free Gingival Graft Simultaneous With Posterior Mandibular Implant
NCT06645925
Guided Versus Non-Guided Harvesting Technique of Soft Tissue Graft in Cairo Recession Type I Sites
NCT06603467
Assessment of Hard and Soft Tissue Changes Following XCM Versus FGG Simultaneous With Delayed Dental Implant Placement
NCT07080177
Xenogenic Collagen Matrix vs. Connective Tissue Graft for Soft Tissue Augmentation Around Early Maxillary Implants
NCT07024186
Efficacy of Collagen Matrix for Peri-implant Soft Tissue Phenotype Modification
NCT07056959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Selected patients were questioned about the cause and time of extractions, whether extractions were because of periodontal disease, dental decay or other causes. Previous experiences with dental procedures were also discussed. Intraoral photographs were taken to record the existing condition of teeth and mucosa before implant placement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 participants underwent free gingival graft placement two months before implant placement.
No interventions assigned to this group
Group2
Group 2 in which the participants underwent the placement of the free gingival graft during the second stage of surgery, specifically at the time of healing abutment placement
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemic Condition: Healthy
* Keratinized Mucosa Width: Less than 2mm at the intended implant site
* Bucco-lingual Bone Width: At least 5.5 mm in a single edentulous space
* Mesio-distal Distance: At least 7 mm between adjacent teeth in a single edentulous space
* Minimal Bone Height: Not less than 10 mm
* Residual Alveolar Ridge: Healthy and well-formed, covered with firm mucosa
* Periodontal Health: Absence of signs of periodontal bone loss or significant soft tissue .loss in teeth adjacent to the implant site
* Inter-arch Space: Adequate, exceeding 7 mm
Exclusion Criteria
* Pregnancy: Individuals with known pregnancies
* Parafunctional Habits: Abnormal parafunctional habits such as bruxism and clenching
* Systemic Illnesses: Patients with systemic illnesses that could disrupt healing
* Medication: Individuals receiving systemic corticosteroids or other drugs impacting .osseointegration or post-operative healing
* Smoking: Smokers consuming more than 10 cigarettes per day
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samah Elmeadawy, Ph.D
Role: STUDY_DIRECTOR
Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wafaa saleh
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A11100221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.